カテゴリー： MarketsandMarkets, 世界, 医療/バイオ

世界のデジタル糖尿病管理市場（～2028年）：製品別（デバイス（CGM、スマートグルコメーター、インスリンパッチポンプ）、糖尿病アプリ、サービス、ソフトウェア＆プラットフォーム）、デバイスタイプ別（ハンドヘルド＆ウェアラブル）、エンドユーザー別（病院＆セルフ／在宅医療）

◆英語タイトル：Digital Diabetes Management Market by Product (Device (CGM, Smart Glucometer, Insulin Patch Pump), Diabetes Apps, Service, Software & Platforms), Device Type (Handheld & Wearables), End User (Hospitals & Self/Home Healthcare) - Global Forecast to 2028
	◆商品コード：MD6871-23 ◆発行会社（リサーチ会社）：MarketsandMarkets ◆発行日：2023年6月30日 ◆ページ数：237 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後24時間以内） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧）	USD4,950 ⇒換算￥752,400	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥1,010,800	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥1,238,800	見積依頼/購入/質問フォーム

★MarketsandMarketsに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

MarketsandMarkets社発行の当調査報告書によると、世界のデジタル糖尿病管理市場規模が2023年168億ドルから2028年313億ドルまで、予測期間中、年平均13.3%成長すると予測されています。当書は、デジタル糖尿病管理の世界市場について広く調査・分析を行い、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品＆サービス別（デバイス、デジタル糖尿病管理アプリ、データ管理ソフトウェア＆プラットフォーム＆サービス）分析、エンドユーザー別（セルフ／在宅医療、病院＆糖尿病専門クリニック、学術＆研究機関）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析、競争状況などの項目をまとめています。なお、参入企業情報として、Medtronic (Ireland)、B. Braun Melsungen AG (Germany)、Dexcom, Inc. (US)、Abbott Laboratories (US)、F. Hoffmann-La Roche (Switzerland)、Insulet Corporation (US)、Tandem Diabetes Care (US)、Dottli (Finland)、Ypsomed Holding AG (Switzerland)、ARKRAY (Japan)などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界のデジタル糖尿病管理市場規模：製品＆サービス別
　 - デジタル糖尿病管理デバイスの市場規模
　 - デジタル糖尿病管理アプリの市場規模
　 - 糖尿病データ管理ソフトウェア＆プラットフォーム＆サービスの市場規模
・世界のデジタル糖尿病管理市場規模：エンドユーザー別
　 - セルフ／在宅医療における市場規模
　 - 病院＆糖尿病専門クリニックにおける市場規模
　 - 学術＆研究機関における市場規模
・世界のデジタル糖尿病管理市場規模：地域別
　 - 北米のデジタル糖尿病管理市場規模
　 - ヨーロッパのデジタル糖尿病管理市場規模
　 - アジア太平洋のデジタル糖尿病管理市場規模
　 - 中南米のデジタル糖尿病管理市場規模
　 - 中東/アフリカのデジタル糖尿病管理市場規模
・競争状況
・企業情報

“世界のデジタル糖尿病管理市場は、2023年の推定168億米ドルから2028年には313億米ドルに達すると予測され、予測期間中の年平均成長率は13.3%”
糖尿病有病率の上昇により、より優れた糖尿病ケアソリューションを開発・導入する意義が高まっています。また、技術開発により、適応性の高いソリューションの導入が可能になりました。その他、クラウドベースの企業向けソリューションの採用が増加していること、コネクテッドデバイスやアプリの利用が増加していることも、市場成長の主な要因のひとつです。しかし、予測期間中は、デバイスコストの高さ、発展途上国での償還不足、標準的で従来の糖尿病管理デバイスの受け入れ拡大などの要因が、市場成長の妨げになると予測されています。

“デジタル糖尿病管理市場で最大シェアを占めるスマートグルコースメーターセグメント”
デバイスセグメントは、スマートインスリンペン、スマートインスリンポンプ/クローズドループシステム、スマートインスリンパッチ、スマートインスリンペン、CGMシステムに細分化されます。2022年のデジタル糖尿病管理機器市場は、スマートグルコースメーター分野が25.2%の市場シェアを占めました。スマートグルコースメーターを使用する際の利便性と、低血糖および高血糖糖尿病の早期発見における利点が、この市場の成長の主な原因となっています。その他、Bluetooth対応グルコメーター、分析機能付きオールインワン型グルコメーター、携帯可能なポケットサイズのグルコメーターなどの技術進歩も、この市場セグメントの人気拡大を後押ししています。

“予測期間中、ウェアラブルデバイス分野が最も高いCAGRで成長”
デジタル糖尿病管理デバイス市場で考慮されるデバイスタイプのサブセグメントには、携帯型デバイスとウェアラブルデバイスの両方があります。2022年には、ウェアラブル技術がデジタル糖尿病管理機器市場の60.3%を占めました。予測期間中、このセグメントの年平均成長率は13.2%と最も高くなると予測されています。ウェアラブル市場は、技術の進歩、スマートインスリンポンプやインスリンパッチの採用増加、ウェアラブルに関する規制認可数の増加などの結果、拡大しています。

“2022年、デジタル糖尿病管理市場でセルフ/ホームヘルスケア分野が最大シェアを占める”
2022年、デジタル糖尿病管理で最大の市場シェアを占めたのはセルフ/ホームヘルスケア分野でした。これは主に、糖尿病管理のためのデジタルプラットフォームに対する認識が高まった結果、在宅医療を受け入れる患者が増加したことに起因します。継続的なインスリン療法を必要とする患者にとって、自己投与は最も有益です。長期的な治療が必要な患者にとって入院治療は非常に高額であり、日常生活に戻ることもできません。

“2021年、北米がデジタル糖尿病管理市場で最大シェアを占める”
2022年の市場シェアは北米が41.4%で最大、次いで欧州が29.0%。接続型糖尿病管理デバイスの成長、糖尿病・肥満管理アプリの人気上昇、技術的に高度なソリューションに対する需要の高まり、支払者によるデジタル糖尿病ソリューションの受け入れ拡大、デジタルヘルスを推進する政府の取り組み、同地域における自己糖尿病管理に対する意識の高まりなどが、北米がデジタル糖尿病管理市場を支配する主な要因となっています。

本レポートで参照したデジタル糖尿病管理市場の主要参入企業（供給側）の内訳は以下の通りです：
– 企業タイプ別ティア1～46％、ティア2～33％、ティア3～21％
– 役職別 Cレベル-43%、ディレクターレベル-35%、その他-22％
– 地域別北米-34%、欧州-26%、アジア太平洋地域-19%、中南米-11%、中東・アフリカ-10％

世界のデジタル糖尿病管理市場で事業を展開している主要企業は、Medtronic (Ireland), B. Braun Melsungen AG (Germany), Dexcom, Inc. (US), Abbott Laboratories (US), F. Hoffmann-La Roche (Switzerland), Insulet Corporation (US), Tandem Diabetes Care (US), Dottli (Finland), Ypsomed Holding AG (Switzerland), ARKRAY (Japan), Ascensia Diabetes Care Holdings AG (Switzerland), Health2Sync (Taiwan), Emperra GmbH E-Health Technologies (Germany), ACON Laboratories, Inc. (US), Care Innovations, LLC (US), Azumio (US), LifeScan, Inc. (US), Tidepool (US), AgaMatrix (US), Glooko, Inc. (US), DarioHealth Corporation (Israel), One Drop (US), Decide Clinical Software GmbH (Austria), Pendiq GmbH (Germany), and BeatO (India).です。

調査対象範囲
この調査レポートは、様々なセグメントにわたるデジタル糖尿病管理市場を対象としています。製品・サービス別、デバイスタイプ別、エンドユーザー別、地域別など、さまざまなセグメントにわたって市場規模や成長性を推定することを目的としています。また、市場主要企業の詳細な競合分析、企業プロフィール、製品および事業内容に関する主な考察、最近の動向、主要な市場戦略も掲載しています。

レポート購入の理由
本レポートは、デジタル糖尿病管理市場全体およびサブセグメントの収益数の最も近い近似値に関する情報を提供し、本市場の市場リーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得ることで、事業の位置づけを高め、適切な市場参入戦略を計画するのに役立ちます。また、本レポートは、関係者が市場動向を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、および機会に関する情報を提供します。

本レポートは、以下のポイントに関する洞察を提供します：
– デジタル糖尿病管理市場の成長に影響を与える主要促進要因（糖尿病の有病率の増加、技術の進歩、糖尿病管理のためのクラウドベースの企業ソリューションの採用拡大）、阻害要因（発展途上国におけるデバイスの高コストと償還の欠如、従来の糖尿病管理デバイスの受け入れ拡大）、機会（新興経済国における糖尿病関連の医療費の増加）、課題（発展途上経済国における普及率の低さ、データセキュリティの欠如）分析
– 市場参入：世界のデジタル糖尿病管理市場におけるトップ企業が提供する製品ポートフォリオに関する包括的情報
– 製品開発/イノベーション：世界のデジタル糖尿病管理市場における今後の動向、研究開発活動、製品・サービスの発売に関する詳細な洞察
– 市場開発：製品・サービス、デバイスタイプ、エンドユーザー、地域別の有利な新興地域に関する包括的情報
– 市場の多様化：世界のデジタル糖尿病管理市場における新製品、成長地域、最新動向に関する詳細情報
– 競合評価：世界のデジタル糖尿病管理市場における主要企業の市場シェア、成長戦略、収益分析、製品に関する詳細な評価。

❖ レポートの目次 ❖

1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
1.2.1 PRODUCT AND SERVICES 32
1.2.2 DEVICE TYPE 33
1.2.3 END USER 34
1.2.4 INCLUSIONS AND EXCLUSIONS 34
1.3 MARKET SCOPE 35
1.3.1 MARKETS COVERED 35
1.3.2 YEARS CONSIDERED 35
1.4 CURRENCY CONSIDERED 36
TABLE 1 STANDARD CURRENCY CONVERSION RATES 36
1.5 LIMITATIONS 36
1.6 STAKEHOLDERS 36
1.7 SUMMARY OF CHANGES 37
1.7.1 REFINEMENTS IN SEGMENTATION OF GLOBAL DIGITAL DIABETES MANAGEMENT MARKET 37
1.7.2 UPDATED FINANCIAL INFORMATION/PRODUCT PORTFOLIOS OF PLAYERS 37
1.7.3 UPDATED MARKET DEVELOPMENTS OF PROFILED PLAYERS 37
1.7.4 ADDITION OF RECESSION IMPACT 37
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH DATA 38
FIGURE 1 RESEARCH DESIGN 38
2.1.1 SECONDARY DATA 39
2.1.1.1 Key data from secondary sources 40
2.1.2 PRIMARY DATA 40
FIGURE 2 PRIMARY SOURCES 40
2.1.2.1 Key data from primary sources 41
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 42
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION 42
2.2 MARKET SIZE ESTIMATION 43
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2022) 43
FIGURE 6 MARKET SIZE ESTIMATION: COMPANY-WISE REVENUE SHARE ANALYSIS (2022) 44
FIGURE 7 SUPPLY-SIDE ANALYSIS: DIGITAL DIABETES MANAGEMENT MARKET (2022) 44
FIGURE 8 SUPPLY-SIDE ANALYSIS: SMART GLUCOSE METERS MARKET (2022) 45
FIGURE 9 SUPPLY-SIDE ANALYSIS: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET (2022) 45
FIGURE 10 SUPPLY-SIDE ANALYSIS: SMART INSULIN PENS MARKET (2022) 46
FIGURE 11 SUPPLY-SIDE ANALYSIS: SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS AND SMART INSULIN PATCHES MARKET (2022) 46
FIGURE 12 SUPPLY-SIDE ANALYSIS: DIGITAL DIABETES MANAGEMENT APPS MARKET (2022) 47
FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR DIGITAL DIABETES MANAGEMENT MARKET (2023–2028) 48
FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF DIGITAL DIABETES MANAGEMENT MARKET 49
FIGURE 15 TOP-DOWN APPROACH: GLOBAL DIGITAL DIABETES MANAGEMENT MARKET 50
FIGURE 16 BOTTOM-UP APPROACH: GLOBAL DIGITAL DIABETES MANAGEMENT MARKET 50
FIGURE 17 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET SIZING, BY DEVICE TYPE 50
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 51
FIGURE 18 DATA TRIANGULATION METHODOLOGY 51
2.4 MARKET SHARE ESTIMATION 52
2.5 STUDY ASSUMPTIONS 52
2.6 IMPACT OF RECESSION 52
3 EXECUTIVE SUMMARY 53
FIGURE 19 DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 53
FIGURE 20 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2023 VS. 2028 (USD MILLION) 54
FIGURE 21 DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 54
FIGURE 22 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 55
FIGURE 23 DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 56
FIGURE 24 DIGITAL DIABETES MANAGEMENT MARKET: GEOGRAPHICAL SNAPSHOT 56
4 PREMIUM INSIGHTS 58
4.1 DIGITAL DIABETES MANAGEMENT MARKET OVERVIEW 58
FIGURE 25 INCREASING PREVALENCE OF DIABETES AND GROWING DEMAND FOR DIGITAL SOLUTIONS TO DRIVE MARKET GROWTH 58
4.2 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022) 59
FIGURE 26 DEVICES TO ACCOUNT FOR LARGEST SHARE OF ASIA PACIFIC MARKET 59
4.3 DIGITAL DIABETES MANAGEMENT MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 60
FIGURE 27 US TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 60
4.4 REGIONAL MIX: DIGITAL DIABETES MANAGEMENT MARKET 61
FIGURE 28 NORTH AMERICAN MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 61
4.5 DIGITAL DIABETES MANAGEMENT MARKET: DEVELOPED VS. DEVELOPING ECONOMIES, 2023 VS. 2028 (USD MILLION) 61
FIGURE 29 DEVELOPED ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 61
5 MARKET OVERVIEW 62
5.1 INTRODUCTION 62
5.2 MARKET DYNAMICS 62
FIGURE 30 DIGITAL DIABETES MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 62
5.2.1 DRIVERS 63
5.2.1.1 Increasing prevalence of diabetes 63
TABLE 2 TOP FIVE COUNTRIES WITH HIGHEST NUMBER OF DIABETICS (20–79 YEARS), 2021 VS. 2045 63
5.2.1.2 Technological advancements 63
TABLE 3 PRODUCT LAUNCHES WITH NEW TECHNOLOGICAL ADVANCEMENTS 64
5.2.1.3 Growing adoption of cloud-based enterprise solutions for diabetes management 64
5.2.1.4 Advent of artificial intelligence in diabetes care devices 65
5.2.1.5 Increasing penetration of digital platforms and adoption of mobile apps for diabetes management 65
5.2.2 RESTRAINTS 66
5.2.2.1 High cost of devices and lack of reimbursement in developing countries 66
5.2.3 OPPORTUNITIES 67
5.2.3.1 Increasing diabetes-related health expenditure 67
5.2.4 CHALLENGES 67
5.2.4.1 Low adoption in developing economies 67
5.2.4.2 Data security 67
5.3 INDUSTRY TRENDS 68
5.3.1 GROWING DEMAND FOR HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS 68
TABLE 4 HYBRID CLOSED-LOOP SYSTEMS: LATEST EXAMPLES 68
5.3.2 GROWING NUMBER OF COLLABORATIONS BETWEEN STAKEHOLDERS 69
TABLE 5 RECENT COLLABORATIONS IN DIGITAL DIABETES MANAGEMENT MARKET 69
5.3.3 INCREASING DEMAND FOR FLASH GLUCOSE MONITORING (FGM) SYSTEMS 70
5.4 REGULATORY ANALYSIS 70
5.4.1 REGULATORY LANDSCAPE 70
5.4.1.1 North America 70
5.4.1.1.1 US 70
TABLE 6 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 70
FIGURE 31 FDA 510(K) APPROVAL PROCESS 71
5.4.1.1.2 Canada 71
TABLE 7 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 71
5.4.1.2 Europe 72
FIGURE 32 CE APPROVAL PROCESS FOR DIGITAL DIABETES MANAGEMENT SOLUTIONS 72
5.4.1.3 Asia Pacific 72
5.4.1.3.1 Australia 72
5.4.1.3.2 Japan 72
TABLE 8 CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY IN JAPAN 73
5.4.1.3.3 China 73
TABLE 9 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 73
5.4.1.3.4 India 73
5.4.1.4 Latin America 74
5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 10 INDICATIVE LIST OF REGULATORY AUTHORITIES 74
5.5 ECOSYSTEM ANALYSIS 75
FIGURE 33 DIGITAL DIABETES MANAGEMENT MARKET: ECOSYSTEM ANALYSIS (2022) 75
5.6 VALUE CHAIN ANALYSIS 76
FIGURE 34 DIGITAL DIABETES MANAGEMENT DEVICES MARKET: VALUE CHAIN ANALYSIS (2022) 76
5.7 PORTER’S FIVE FORCES ANALYSIS 76
TABLE 11 DIGITAL DIABETES MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 76
5.7.1 THREAT OF NEW ENTRANTS 77
5.7.2 INTENSITY OF COMPETITIVE RIVALRY 77
5.7.3 BARGAINING POWER OF BUYERS 78
5.7.4 BARGAINING POWER OF SUPPLIERS 78
5.7.5 THREAT OF SUBSTITUTES 78
5.8 PATENT ANALYSIS 79
5.8.1 PATENT PUBLICATION TRENDS FOR DIGITAL DIABETES MANAGEMENT 79
FIGURE 35 PATENT PUBLICATION TRENDS (JANUARY 2014–MAY 2023) 79
5.8.2 TOP APPLICANTS (COMPANIES) FOR DIGITAL DIABETES MANAGEMENT PATENTS 80
FIGURE 36 TOP APPLICANT COMPANIES FOR DIGITAL DIABETES MANAGEMENT PATENTS, 2014–2023 80
5.8.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR DIGITAL DIABETES MANAGEMENT PATENTS 81
FIGURE 37 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR DIGITAL DIABETES MANAGEMENT PATENTS, 2014–2023 81
5.9 PRICING ANALYSIS 81
5.9.1 KEY PLAYERS: AVERAGE SELLING PRICE, BY DEVICE 81
TABLE 12 AVERAGE SELLING PRICE, BY DEVICE, 2022 81
5.10 SUPPLY CHAIN ANALYSIS 82
FIGURE 38 DIGITAL DIABETES MANAGEMENT MARKET: STAKEHOLDERS IN SUPPLY CHAIN 83
5.11 KEY CONFERENCES AND EVENTS IN 2023–2024 83
TABLE 13 DIGITAL DIABETES MANAGEMENT MARKET: LIST OF CONFERENCES AND EVENTS 83
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 84
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 84
FIGURE 39 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS 84
TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS (%) 84
5.12.2 BUYING CRITERIA 85
FIGURE 40 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 85
TABLE 15 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 85
5.13 TECHNOLOGY ANALYSIS 85
5.14 REIMBURSEMENT SCENARIO 86
TABLE 16 DIGITAL DIABETES MANAGEMENT PRODUCTS: GLOBAL COVERAGE AND REIMBURSEMENT 86
5.15 TRADE ANALYSIS 88
TABLE 17 TOP EXPORTERS OF DIGITAL DIABETES MANAGEMENT DEVICES, BY COUNTRY (2022) 88
TABLE 18 TOP IMPORTERS OF DIGITAL DIABETES MANAGEMENT DEVICES, BY COUNTRY (2022) 88
6 DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE 89
6.1 INTRODUCTION 90
TABLE 19 DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 90
6.2 DEVICES 90
TABLE 20 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 91
TABLE 21 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 22 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (THOUSAND UNITS) 92
6.2.1 SMART GLUCOSE METERS 92
6.2.1.1 Reducing prices and technological innovations to drive growth 92
TABLE 23 KEY SMART GLUCOSE METERS OFFERED BY MARKET PLAYERS 93
TABLE 24 SMART GLUCOSE METERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 25 SMART GLUCOSE METERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 95
6.2.2 CONTINUOUS GLUCOSE MONITORING SYSTEMS 95
6.2.2.1 CGM segment to grow at highest CAGR during forecast period 95
TABLE 26 KEY CGM SYSTEMS OFFERED BY MARKET PLAYERS 96
TABLE 27 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 28 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 97
6.2.3 SMART INSULIN PENS 98
6.2.3.1 Increasing demand for personalized/patient-centric devices without risk of needle-stick injuries to drive growth 98
TABLE 29 KEY SMART INSULIN PENS OFFERED BY MARKET PLAYERS 98
TABLE 30 SMART INSULIN PENS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 31 SMART INSULIN PENS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 99
6.2.4 SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS AND SMART INSULIN PATCHES 100
6.2.4.1 Benefits of smart insulin pumps and closed-loop systems to drive growth 100
TABLE 32 KEY SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS AND SMART INSULIN PATCHES OFFERED BY MARKET PLAYERS 101
TABLE 33 SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS AND SMART INSULIN PATCHES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 34 SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS AND SMART INSULIN PATCHES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 102
6.3 DIGITAL DIABETES MANAGEMENT APPS 103
TABLE 35 DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 103
TABLE 36 DIGITAL DIABETES MANAGEMENT APPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 104
6.3.1 DIABETES AND BLOOD GLUCOSE TRACKING APPS 104
6.3.1.1 Growing adoption of connected devices to drive growth 104
TABLE 37 KEY DIABETES AND BLOOD GLUCOSE TRACKING APPS OFFERED BY MARKET PLAYERS 105
TABLE 38 DIABETES AND BLOOD GLUCOSE TRACKING APPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 106
6.3.2 WEIGHT AND DIET MANAGEMENT APPS 106
6.3.2.1 Growing obese population and increasing need to prevent diabetes to drive growth 106
TABLE 39 KEY WEIGHT AND DIET MANAGEMENT APPS OFFERED BY MARKET PLAYERS 107
TABLE 40 WEIGHT AND DIET MANAGEMENT APPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
6.4 DATA MANAGEMENT SOFTWARE AND PLATFORMS 108
6.4.1 GROWING DEMAND FOR DIABETES DATA MANAGEMENT TO DRIVE GROWTH 108
TABLE 41 KEY DATA MANAGEMENT SOFTWARE AND PLATFORMS OFFERED BY MARKET PLAYERS 108
TABLE 42 DATA MANAGEMENT SOFTWARE AND PLATFORMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
6.5 SERVICES 110
6.5.1 INCREASING ADOPTION OF REMOTE ONLINE COACHING SERVICES AMONG DIABETES PATIENTS TO DRIVE GROWTH 110
TABLE 43 KEY SERVICES OFFERED BY MARKET PLAYERS 110
TABLE 44 DIGITAL DIABETES MANAGEMENT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
7 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE 112
7.1 INTRODUCTION 113
TABLE 45 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 113
7.2 WEARABLE DEVICES 113
7.2.1 WEARABLE DEVICES TO DOMINATE DIGITAL DIABETES MANAGEMENT DEVICES MARKET DURING FORECAST PERIOD 113
TABLE 46 WEARABLE DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
7.3 HANDHELD DEVICES 114
7.3.1 INCREASING DEMAND FOR REMOTE MONITORING TO BOOST GROWTH 114
TABLE 47 HANDHELD DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
8 DIGITAL DIABETES MANAGEMENT MARKET, BY END USER 116
8.1 INTRODUCTION 117
TABLE 48 DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 117
8.2 SELF/HOME HEALTHCARE 117
8.2.1 HIGH COST OF INPATIENT CARE TO FUEL PREFERENCE FOR SELF/HOME CARE 117
TABLE 49 DIGITAL DIABETES MANAGEMENT MARKET FOR SELF/HOME HEALTHCARE, BY COUNTRY, 2021–2028 (USD MILLION) 118
8.3 HOSPITALS AND SPECIALTY DIABETES CLINICS 118
8.3.1 RISING DEMAND FOR POC TESTING IN HOSPITALS TO BOOST GROWTH 118
TABLE 50 DIGITAL DIABETES MANAGEMENT MARKET FOR HOSPITALS AND SPECIALTY DIABETES CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 119
8.4 ACADEMIC AND RESEARCH INSTITUTES 119
8.4.1 PRODUCT INNOVATION FOR DIABETES MANAGEMENT TO DRIVE GROWTH 119
TABLE 51 DIGITAL DIABETES MANAGEMENT MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 120
9 DIGITAL DIABETES MANAGEMENT MARKET, BY REGION 121
9.1 INTRODUCTION 122
FIGURE 41 DIGITAL DIABETES MANAGEMENT MARKET: GEOGRAPHIC SNAPSHOT 122
TABLE 52 DIGITAL DIABETES MANAGEMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 122
9.2 NORTH AMERICA 123
9.2.1 NORTH AMERICA: RECESSION IMPACT 123
FIGURE 42 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET SNAPSHOT 124
TABLE 53 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 54 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 125
TABLE 55 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 125
TABLE 56 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 57 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 126
TABLE 58 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 126
9.2.2 US 126
9.2.2.1 Increasing diabetes prevalence and high penetration of digital platforms to boost market 126
TABLE 59 US: MACROECONOMIC INDICATORS 127
TABLE 60 US: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 127
TABLE 61 US: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 128
TABLE 62 US: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 128
TABLE 63 US: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 128
TABLE 64 US: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 129
9.2.3 CANADA 129
9.2.3.1 Favorable reimbursement scenario to drive digital diabetes management adoption in Canada 129
TABLE 65 CANADA: MACROECONOMIC INDICATORS 129
TABLE 66 CANADA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 130
TABLE 67 CANADA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 130
TABLE 68 CANADA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 69 CANADA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 70 CANADA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 131
9.3 EUROPE 132
9.3.1 EUROPE: RECESSION IMPACT 132
FIGURE 43 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET SNAPSHOT 133
TABLE 71 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 72 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 134
TABLE 73 EUROPE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 135
TABLE 74 EUROPE: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 135
TABLE 75 EUROPE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 135
TABLE 76 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 136
9.3.2 GERMANY 136
9.3.2.1 Germany to dominate European market over forecast period 136
TABLE 77 GERMANY: MACROECONOMIC INDICATORS 136
TABLE 78 GERMANY: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 137
TABLE 79 GERMANY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 137
TABLE 80 GERMANY: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 81 GERMANY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 82 GERMANY: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 138
9.3.3 UK 139
9.3.3.1 Government initiatives to support market growth 139
TABLE 83 UK: MACROECONOMIC INDICATORS 139
TABLE 84 UK: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 139
TABLE 85 UK: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 140
TABLE 86 UK: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 140
TABLE 87 UK: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 140
TABLE 88 UK: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 141
9.3.4 FRANCE 141
9.3.4.1 Affordability of healthcare to propel adoption of digital solutions 141
TABLE 89 FRANCE: MACROECONOMIC INDICATORS 141
TABLE 90 FRANCE: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 142
TABLE 91 FRANCE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 142
TABLE 92 FRANCE: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 93 FRANCE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 94 FRANCE: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 143
9.3.5 ITALY 144
9.3.5.1 Rising diabetes prevalence to offer growth opportunities 144
TABLE 95 ITALY: MACROECONOMIC INDICATORS 144
TABLE 96 ITALY: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 145
TABLE 97 ITALY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 145
TABLE 98 ITALY: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 146
TABLE 99 ITALY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 146
TABLE 100 ITALY: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 146
9.3.6 SPAIN 147
9.3.6.1 Growing healthcare budget and efforts to boost local manufacturing of medical products 147
TABLE 101 SPAIN: MACROECONOMIC INDICATORS 147
TABLE 102 SPAIN: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 148
TABLE 103 SPAIN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 148
TABLE 104 SPAIN: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 148
TABLE 105 SPAIN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 106 SPAIN: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 149
9.3.7 REST OF EUROPE 149
TABLE 107 REST OF EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 150
TABLE 108 REST OF EUROPE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 150
TABLE 109 REST OF EUROPE: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 110 REST OF EUROPE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 111 REST OF EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 151
9.4 ASIA PACIFIC 152
9.4.1 ASIA PACIFIC: RECESSION IMPACT 152
FIGURE 44 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET SNAPSHOT 153
TABLE 112 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 113 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 154
TABLE 114 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 155
TABLE 115 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 116 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 117 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 156
9.4.2 CHINA 156
9.4.2.1 China to hold largest share of APAC market 156
TABLE 118 CHINA: MACROECONOMIC INDICATORS 157
TABLE 119 CHINA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 157
TABLE 120 CHINA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 158
TABLE 121 CHINA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 122 CHINA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 123 CHINA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 159
9.4.3 JAPAN 159
9.4.3.1 High acceptance of digital solutions for diabetes management to boost growth 159
TABLE 124 JAPAN: MACROECONOMIC INDICATORS 160
TABLE 125 JAPAN: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 160
TABLE 126 JAPAN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 161
TABLE 127 JAPAN: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 128 JAPAN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 129 JAPAN: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 162
9.4.4 INDIA 162
9.4.4.1 Rising diabetes prevalence and focus on cost curtailment to favor adoption 162
TABLE 130 INDIA: MACROECONOMIC INDICATORS 162
TABLE 131 INDIA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 163
TABLE 132 INDIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 163
TABLE 133 INDIA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 134 INDIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 135 INDIA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 164
9.4.5 AUSTRALIA 165
9.4.5.1 Initiatives to help treat or manage diabetes-related problems to drive market growth 165
TABLE 136 AUSTRALIA: MACROECONOMIC INDICATORS 165
TABLE 137 AUSTRALIA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 165
TABLE 138 AUSTRALIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 166
TABLE 139 AUSTRALIA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 140 AUSTRALIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 141 AUSTRALIA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 167
9.4.6 SOUTH KOREA 167
9.4.6.1 Government initiatives for diabetes management to drive growth 167
TABLE 142 SOUTH KOREA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 167
TABLE 143 SOUTH KOREA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 168
TABLE 144 SOUTH KOREA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 145 SOUTH KOREA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 146 SOUTH KOREA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 169
9.4.7 REST OF ASIA PACIFIC 169
TABLE 147 REST OF ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 169
TABLE 148 REST OF ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 170
TABLE 149 REST OF ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 150 REST OF ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 151 REST OF ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 171
9.5 LATIN AMERICA 171
9.5.1 LATIN AMERICA: RECESSION IMPACT 171
TABLE 152 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 172
TABLE 153 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 172
TABLE 154 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 172
TABLE 155 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 156 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 157 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 173
9.5.2 BRAZIL 174
9.5.2.1 High private healthcare expenditure and increasing geriatric population to drive market 174
TABLE 158 BRAZIL: MACROECONOMIC INDICATORS 174
TABLE 159 BRAZIL: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 175
TABLE 160 BRAZIL: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 175
TABLE 161 BRAZIL: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 162 BRAZIL: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 163 BRAZIL: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 176
9.5.3 MEXICO 176
9.5.3.1 Growing obesity rate in Mexico to drive market 176
TABLE 164 MEXICO: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 177
TABLE 165 MEXICO: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 177
TABLE 166 MEXICO: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 167 MEXICO: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 168 MEXICO: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 178
9.5.4 REST OF LATIN AMERICA 178
TABLE 169 REST OF LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 179
TABLE 170 REST OF LATIN AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 179
TABLE 171 REST OF LATIN AMERICA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 172 REST OF LATIN AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 173 REST OF LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 180
9.6 MIDDLE EAST & AFRICA 180
9.6.1 SLOW DIGITIZATION OF HEALTH SYSTEMS IN AFRICAN COUNTRIES TO AFFECT GROWTH 180
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 181
TABLE 174 AFRICA: MACROECONOMIC INDICATORS 181
TABLE 175 MIDDLE EAST & AFRICA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 181
TABLE 176 MIDDLE EAST & AFRICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION) 182
TABLE 177 MIDDLE EAST & AFRICA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 178 MIDDLE EAST & AFRICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 179 MIDDLE EAST & AFRICA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 183
10 COMPETITIVE LANDSCAPE 184
10.1 OVERVIEW 184
10.2 STRATEGIES OF KEY PLAYERS/RIGHT TO WIN 184
FIGURE 45 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DIGITAL DIABETES MANAGEMENT MARKET 185
10.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN DIGITAL DIABETES MANAGEMENT MARKET 186
FIGURE 46 REVENUE SHARE ANALYSIS OF KEY PLAYERS OPERATING IN DIGITAL DIABETES MANAGEMENT MARKET (2018–2022) 186
10.4 MARKET SHARE ANALYSIS 187
FIGURE 47 MARKET SHARE ANALYSIS: SMART GLUCOSE METERS MARKET (2022) 187
FIGURE 48 MARKET SHARE ANALYSIS: CONTINUOUS GLUCOSE MONITORING DEVICES MARKET (2022) 187
FIGURE 49 MARKET SHARE ANALYSIS: INSULIN PUMPS MARKET (2022) 188
FIGURE 50 MARKET SHARE ANALYSIS: SMART INSULIN PENS MARKET (2022) 188
FIGURE 51 MARKET SHARE ANALYSIS: DIABETES APPS MARKET (2022) 188
10.5 COMPANY EVALUATION MATRIX 189
FIGURE 52 DIGITAL DIABETES MANAGEMENT MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 190
10.5.1 STARS 191
10.5.2 EMERGING LEADERS 191
10.5.3 PERVASIVE PLAYERS 191
10.5.4 PARTICIPANTS 191
10.6 EVALUATION MATRIX FOR START-UP/SME PLAYERS (2022) 191
FIGURE 53 DIGITAL DIABETES MANAGEMENT MARKET: COMPANY EVALUATION MATRIX FOR START-UP/SME PLAYERS, 2022 192
10.6.1 PROGRESSIVE COMPANIES 192
10.6.2 DYNAMIC COMPANIES 192
10.6.3 STARTING BLOCKS 193
10.6.4 RESPONSIVE COMPANIES 193
10.7 COMPETITIVE BENCHMARKING 193
10.7.1 OVERALL FOOTPRINT OF COMPANIES 193
TABLE 180 OVERALL FOOTPRINT OF COMPANIES 193
TABLE 181 COMPANY FOOTPRINT: BY PRODUCT & SERVICE 194
TABLE 182 COMPANY FOOTPRINT: BY DEVICE TYPE 195
TABLE 183 COMPANY FOOTPRINT: BY END USER 196
TABLE 184 COMPANY FOOTPRINT: BY REGION 197
10.8 COMPETITIVE SCENARIO 198
10.8.1 PRODUCT LAUNCHES 198
TABLE 185 PRODUCT LAUNCHES 198
10.8.2 DEALS 199
TABLE 186 DEALS 199
11 COMPANY PROFILES 200
11.1 KEY PLAYERS 200
(Business overview, Products & services offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and competitive threats)*
11.1.1 MEDTRONIC 200
TABLE 187 MEDTRONIC: BUSINESS OVERVIEW 200
FIGURE 54 MEDTRONIC: COMPANY SNAPSHOT (2022) 201
11.1.2 F. HOFFMANN-LA ROCHE 204
TABLE 188 F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW 204
FIGURE 55 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2022) 205
11.1.3 DEXCOM, INC. 208
TABLE 189 DEXCOM, INC.: BUSINESS OVERVIEW 208
FIGURE 56 DEXCOM, INC.: COMPANY SNAPSHOT (2022) 208
11.1.4 ASCENSIA DIABETES CARE HOLDINGS AG 211
TABLE 190 ASCENSIA DIABETES CARE HOLDINGS AG: BUSINESS OVERVIEW 211
11.1.5 ABBOTT LABORATORIES 213
TABLE 191 ABBOTT LABORATORIES: BUSINESS OVERVIEW 213
FIGURE 57 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022) 214
11.1.6 B. BRAUN MELSUNGEN AG 217
TABLE 192 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW 217
FIGURE 58 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022) 218
11.1.7 TIDEPOOL 219
TABLE 193 TIDEPOOL: BUSINESS OVERVIEW 219
11.1.8 GLOOKO, INC. 220
TABLE 194 GLOOKO, INC.: BUSINESS OVERVIEW 220
11.1.9 LIFESCAN, INC. 222
TABLE 195 LIFESCAN, INC.: BUSINESS OVERVIEW 222
11.1.10 AGAMATRIX 224
TABLE 196 AGAMATRIX: BUSINESS OVERVIEW 224
11.1.11 TANDEM DIABETES CARE, INC. 225
TABLE 197 TANDEM DIABETES CARE, INC.: BUSINESS OVERVIEW 225
FIGURE 59 TANDEM DIABETES CARE, INC.: COMPANY SNAPSHOT (2022) 225
11.1.12 INSULET CORPORATION 227
TABLE 198 INSULET CORPORATION: BUSINESS OVERVIEW 227
FIGURE 60 INSULET CORPORATION: COMPANY SNAPSHOT (2022) 227
11.1.13 DARIOHEALTH CORPORATION 229
TABLE 199 DARIOHEALTH CORPORATION: BUSINESS OVERVIEW 229
FIGURE 61 DARIOHEALTH CORPORATION: COMPANY SNAPSHOT (2022) 229
11.1.14 ONE DROP 231
TABLE 200 ONE DROP: BUSINESS OVERVIEW 231
11.1.15 YPSOMED HOLDING AG 232
TABLE 201 YPSOMED HOLDING AG: BUSINESS OVERVIEW 232
FIGURE 62 YPSOMED HOLDING AG: COMPANY SNAPSHOT (2022) 232
11.2 OTHER PLAYERS 234
11.2.1 ARKRAY 234
11.2.2 DOTTLI 234
11.2.3 ACON LABORATORIES, INC. 234
11.2.4 CARE INNOVATIONS, LLC 235
11.2.5 HEALTH2SYNC 235
11.2.6 EMPERRA GMBH E-HEALTH TECHNOLOGIES 235
11.2.7 AZUMIO 236
11.2.8 DECIDE CLINICAL SOFTWARE GMBH 236
11.2.9 PENDIQ GMBH 236
11.2.10 BEATO 237
*Details on Business overview, Products & services offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX 238
12.1 DISCUSSION GUIDE 238
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 242
12.3 CUSTOMIZATION OPTIONS 244
12.4 RELATED REPORTS 244
12.5 AUTHOR DETAILS 245

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のデジタル糖尿病管理市場（～2028年）：製品別（デバイス（CGM、スマートグルコメーター、インスリンパッチポンプ）、糖尿病アプリ、サービス、ソフトウェア＆プラットフォーム）、デバイスタイプ別（ハンドヘルド＆ウェアラブル）、エンドユーザー別（病院＆セルフ／在宅医療）(Digital Diabetes Management Market by Product (Device (CGM, Smart Glucometer, Insulin Patch Pump), Diabetes Apps, Service, Software & Platforms), Device Type (Handheld & Wearables), End User (Hospitals & Self/Home Healthcare) - Global Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp